Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: A secondary analysis from the SPS3 randomised trial

The Lancet Neurology

Volumn 13, Issue 12, 2014, Pages 1177-1185

  Pearce, Lesly A ^a   McClure, Leslie A ^b   Anderson, David C ^c   Jacova, Claudia ^d   Sharma, Mukul ^e   Hart, Robert G ^e   Benavente, Oscar R ^f  

^a Biostatistical Consulting   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

^d PACIFIC UNIVERSITY   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR DISEASE; COGNITION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; LACUNAR STROKE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NORTH AMERICA; RISK REDUCTION; SECONDARY ANALYSIS; SOUTH AND CENTRAL AMERICA; SPAIN; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECTS; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; STROKE, LACUNAR; TIME;

AGED; ASPIRIN; BLOOD PRESSURE; COGNITION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STROKE, LACUNAR; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84919340367     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70224-8     Document Type: Article

References (36)

1. Jacova C, Pearce LA, Costello R, et al. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 2012, 72:351-362.
2. Leys D, Hénon H, Mackowiak-Cordoliani M-A, Pasquier F Poststroke dementia. Lancet Neurol 2005, 4:752-759.
3. Pendlebury ST, Rothwell PM Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009, 8:1006-1018.
4. Skoog I, Gustafson D Update on hypertension and Alzheimer's disease. Neurol Res 2006, 28:605-611.
5. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
6. Makin SD, Turpin S, Dennis MS, Wardlaw JM Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry 2013, 84:893-900.
7. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-1041. PROGRESS Collaborative Group.
8. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013, 382:507-515. The SPS3 Study Group.
9. Gueyffier F, Boissel JP, Boutitie F, et al. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. Stroke 1997, 28:2557-2562.
10. Diener HC, Sacco RL, Yusuf S, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008, 7:875-884. for the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group.
11. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003, 163:1069-1075.
12. Anderson C, Teo K, Gao P, et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2011, 10:43-53. for the ONTARGET and TRANSCEND Investigators.
13. Forette F, Seux M-L, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347-1351. on behalf of the Syst-Eur Investigators.
14. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008, 7:683-689. for the HYVET investigators.
15. Douiri A, McKevitt C, Emmett ES, Rudd AG, Wolfe CD Long-term effects of secondary prevention on cognitive function in stroke patients. Circulation 2013, 128:1341-1348.
16. Mavaddat N, Roalfe A, Fletcher K, et al. Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study). Stroke 2014, 45:1381-1386.
17. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012, 367:817-825. The SPS3 Investigators.
18. Benavente OR, White CL, Pearce L, et al. The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke 2011, 6:164-175. for the SPS3 Investigators.
19. Benavente OR, Pearce LA, Bazan C, et al. Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial. Int J Stroke 2014, for the SPS3 Investigators, published online May 27. 10.1111/ijs.12282.
20. White CL, Szychowski JM, Roldan A, et al. Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis 2013, 22:764-774.
21. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994, 6:45-58.
22. McCurry SM, Edland SD, Teri L, et al. The cognitive abilities screening instrument (CASI): data from a cohort of 2524 cognitively intact elderly. Int J Geriatr Psychiatry 1999, 14:882-888.
23. Delis DC, Kramer JH, Kaplan E, Ober BA California verbal learning test: adult version 1987, The Psychological Corporation, San Antonio.
24. Royall DR, Cordes JA, Polk M CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998, 64:588-594.
25. Ruff RM, Parker SB Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skills 1993, 76:1219-1230.
26. Tombaugh TN, Kozak J, Rees L Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999, 14:167-177.
27. Wechsler D WAIS-III: administration and scoring manual 1997, The Psychological Corporation-Harcout Brace & Company, San Antonio.
28. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004, 256:240-246.
29. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001, 58:1985-1992.
30. Conover WJ, Iman RL Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 1981, 35:124-129.
31. Nyenhuis DL, Gorelick PB, Freels S, Garron DC Cognitive and functional decline in African Americans with VaD, AD, and stroke without dementia. Neurology 2002, 58:56-61.
32. Skoog I, Lithell H, Hansson L, et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens 2005, 18:1052-1059.
33. Williams PS, Spector A, Orrell M, Rands G Aspirin for vascular dementia. Cochrane Database Syst Rev 2000, 2. CD001296.
34. Peila R, White LR, Masaki K, Petrovitch H, Launer LJ Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 2006, 37:1165-1170.
35. Folstein MF, Folstein SE, McHugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
36. Edwards JD, Jacova C, Sepehry AA, Pratt B, Benavente OR A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke. Neurology 2013, 80:315-322.